Business
Single-shot Johnson & Johnson vaccine ‘highly effective’ in preventing severe COVID-19 – SBS News
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe disease was 85.9 per cent in the United States, 81.7 per cent in South Africa,…
The single-shot Johnson & Johnson vaccine is highly effective in preventing severe COVID-19, including newer variants, according to documents released by the US Food and Drug Administration.
The news on Wednesday came as the US regulator was set to convene an independent panel Friday that will likely vote to authorise the vaccine, making it the third available in the country hit hardest by the coronavirus pandemic.
In large clinical trials, the Johnson & Johnson vaccine’s efficacy against severe…
-
General24 hours agoBruce Lehrmann’s defence applies for messages allegedly sent to rape complainant by Network Ten lawyer in defamation case
-
General22 hours ago‘I love Australian people’: Iran ambassador speaks out
-
Noosa News24 hours agoThe ‘architect of modern Queensland’ farewelled in Brisbane
-
Noosa News22 hours agoMan avoids jail for assaulting Brisbane bus driver, appears from custody on unrelated charges